Announce Date | 05/07/2025 |
EPS Normalized Actual | $0.59 (Beat by $0.05) |
EPS GAAP Actual | $0.59 (Beat by $0.05) |
Revenue Actual | $1.262B |
Revenue Surprise | Beat by $1262M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $0.57559 |
EPS GAAP Estimate | $0.57559 |
Revenue Estimate | $1.385950181B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 3.62 | 8.42 | 3.50556 | 3.74165 | 1 |
Dec 2027 | 2.88 | 10.59 | 2.81489 | 2.93406 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.45 | -0.06039 | 1.262B | -2.54% | -73.7M |
FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 1.311B | 1.05% | 1311M |
FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 1.32B | 0.83% | 1320M |
FQ1 2013 (Mar 2013) | -0.13 | -0.13 | 1.0623B | 100% | 1062.3M |
FQ2 2013 (Jun 2013) | -0.64 | -0.64 | 1.0623B | 100% | 1062.3M |
FQ4 2013 (Dec 2013) | -0.25 | -0.25 | 1.1067B | 100% | 1106.7M |
FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 1.351B | 100% | 1351M |
FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 1.294B | 100% | 1294M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
0.57559
Consensus Revenue Estimates
1.385950181B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 0.89 | -- | 0.86554 | 0.91393 | 4 |
FQ2 2027 (Jun 2027) | 0.89 | -- | 0.86554 | 0.91393 | 3 |
FQ1 2027 (Mar 2027) | 0.74482 | -- | 0.72354 | 0.764 | 4 |
FQ4 2026 (Oct 2026) | 0.64491 | -- | 0.63505 | 0.65423 | 7 |
FQ3 2026 (Jul 2026) | 0.65483 | -- | 0.64481 | 0.66429 | 4 |
FQ2 2026 (Jun 2026) | 0.60893 | -- | 0.59212 | 0.63043 | 4 |
FQ1 2026 (Mar 2026) | 0.51984 | 13.43 | 0.50549 | 0.53819 | 4 |
FQ4 2025 (Oct 2025) | 0.57456 | -9.65 | 0.56577 | 0.58286 | 7 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2027 (Sep 2027) | 1.46B | -- | 1.43B | 1.49B | 4 |
FQ2 2027 (Jun 2027) | 1.49B | -- | 1.46B | 1.52B | 6 |
FQ1 2027 (Mar 2027) | 1.41B | -- | 1.38B | 1.44B | 8 |
FQ4 2026 (Oct 2026) | 1.44B | -- | 1.42B | 1.46B | 4 |
FQ3 2026 (Jul 2026) | 1.44B | -- | 1.42B | 1.45B | 4 |
FQ2 2026 (Jun 2026) | 1.41B | -- | 1.38B | 1.45B | 5 |
FQ1 2026 (Mar 2026) | 1.38B | 8.78 | 1.35B | 1.42B | 5 |
FQ4 2025 (Oct 2025) | 1.39B | 5.64 | 1.37B | 1.4B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
4
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.51039 | 0.45 | -0.06039 | -13.42% |
FQ4 2024 (Dec 2024) | 0.63 | 0.63 | 100% | |
FQ3 2024 (Sep 2024) | 0.46 | 0.46 | 100% | |
FQ1 2013 (Mar 2013) | -0.13 | -0.13 | 100% | |
FQ2 2013 (Jun 2013) | -0.64 | -0.64 | 100% | |
FQ4 2013 (Dec 2013) | -0.25 | -0.25 | 100% | |
FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 100% | |
FQ1 2024 (Mar 2024) | 0.18 | 0.18 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.34B | $1.26B | $-73.7M | -5.84% |
FQ4 2024 (Dec 2024) | $0B | $1.31B | $1311M | 100% |
FQ3 2024 (Sep 2024) | $0B | $1.32B | $1320M | 100% |
FQ1 2013 (Mar 2013) | $0B | $1.06B | $1062.3M | 100% |
FQ2 2013 (Jun 2013) | $0B | $1.06B | $1062.3M | 100% |
FQ4 2013 (Dec 2013) | $0B | $1.11B | $1106.7M | 100% |
FQ2 2024 (Jun 2024) | $0B | $1.35B | $1351M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.29B | $1294M | 100% |